MicroRNA Expression Signature Is Altered in the Cardiac Remodeling Induced by High Fat Diets

Journal of Cellular Physiology

Volumn 231, Issue 8, 2016, Pages 1771-1783

  Guedes, Elaine Castilho ^a   França, Gustavo Starvaggi ^a,b   Lino, Caroline Antunes ^a   Koyama, Fernanda Christtanini ^b   do Nascimento Moreira, Luana ^a   Alexandre, Juliana Gomes ^a   Barreto Chaves, Maria Luiza M ^a   Galante, Pedro Alexandre Favoretto ^b   Diniz, Gabriela Placoná ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 1198 5P; MICRORNA 125A 3P; MICRORNA 126A 5P; MICRORNA 130B 5P; MICRORNA 134 5P; MICRORNA 139 5P; MICRORNA 144 3P; MICRORNA 15A 3P; MICRORNA 195A 3P; MICRORNA 20A 3P; MICRORNA 21A 3P; MICRORNA 21A 5P; MICRORNA 22 5P; MICRORNA 26B 5P; MICRORNA 29B 3P; MICRORNA 29C; MICRORNA 29C 3P; MICRORNA 3069 3P; MICRORNA 328 3P; MICRORNA 338 5P; MICRORNA 34B 3P; MICRORNA 504 3P; MICRORNA 671 5P; MICRORNA 675 3P; MICRORNA 677 5P; MICRORNA 7225 3P; MICRORNA 7225 5P; MICRORNA 99B 5P; UNCLASSIFIED DRUG; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INSULIN; SLC2A4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; INSULIN BLOOD LEVEL; LIPID DIET; LOW FAT DIET; MALE; METABOLIC PARAMETERS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ANALYSIS; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ANIMAL; BIOLOGY; C57BL MOUSE; CARDIAC MUSCLE CELL; CARDIOMEGALY; CELL CULTURE; COMPARATIVE STUDY; DISEASE MODEL; DYSLIPIDEMIA; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEART VENTRICLE REMODELING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; TIME FACTOR; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN SYNTHASE KINASE 3; INSULIN; MALE; MICE, INBRED C57BL; MICRORNAS; MYOCYTES, CARDIAC; RATS, WISTAR; SIGNAL TRANSDUCTION; TIME FACTORS; VENTRICULAR REMODELING;

EID: 84952837388     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25280     Document Type: Article

References (75)

1. Abdellatif M. 2012. Differential expression of microRNAs in different disease states. Circ Res 110:638-650.
2. Abdurrachim D, Ciapaite J, Wessels B, Nabben M, Luiken JJ, Nicolay K, Prompers JJ. 2014. Cardiac diastolic dysfunction in high-fat diet fed mice is associated with lipotoxicity without impairment of cardiac energetics in vivo. Biochem Biophys Acta 1841:1525-1537.
3. Abel ED, Litwin SE, Sweeney G. 2008. Cardiac remodeling in obesity. Physiol Rev 88:389-419.
4. Barreto-Chaves ML, Heimann A, Krieger JE. 2000. Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes. Braz J Med Biol Res 33:661-664.
5. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
6. Calligaris SD, Lecanda M, Solis F, Ezquer M, Gutiérrez J, Brandan E, Leiva A, Sobrevia L, Conget P. 2013. Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: An animal model to study the early phases of diabetic cardiomyopathy. PLoS ONE 8:e60931.
7. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang DZ. 2009. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119:2772-2786.
8. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613-618.
9. Carrer M, Liu N, Grueter CE, Williams AH, Frisard MI, Hulver MW, Bassel-Duby R, Olson EN. 2012. Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. Proc Natl Acad Sci USA 109:15330-15335.
10. Ceylan-Isik AF, Kandadi MR, Xu X, Hua Y, Chicco AJ, Ren J, Nair S. 2013. Apelin administration ameliorates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J Mol Cell Cardiol 63:4-13.
11. Chavali V, Tyagi SC, Mishra PK. 2014. Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts. Cell Biochem Biophys 68:25-35.
12. Cintra DE, Ropelle ER, Moraes JC, Pauli JR, Morari J, Souza CT, Grimaldi R, Stahl M, Carvalheira JB, Saad MJ, Velloso LA. 2012. Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PLoS ONE 7:e30571.
13. Da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der Nagel R, van Kuik J, de Weger R, de Bruin A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ. 2010. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12:1220-1227.
14. Da Costa Martins PA, De Windt LJ. 2012. MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res 93:563-572.
15. Da Silva ND, Jr., Fernandes T, Soci UP, Monteiro AW, Phillips MI, Oliveira DE. 2012. Swimming training in rats increases cardiac MicroRNA-126 expression and angiogenesis. Med Sci Sports Exerc 44:1453-1462.
16. Diniz GP, Lino CA, Guedes EC, Nascimento Moreira Ld, Barreto-Chaves ML. 2015. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via type 1 Angiotensin II receptor. Basic Res Cardiol 110:49.
17. Diniz GP, Takano AP, Barreto-Chaves ML. 2013. MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy-Role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation. Mol Cell Endocrinol 374:117-124.
18. Felipe F, Bonet ML, Ribot J, Palou A. 2003. Up-regulation of muscle uncoupling protein 3 gene expression in mice following high fat diet, dietary vitamin A supplementation and acute retinoic acid-treatment. Int J Obes Relat Metab Disord 27:60-69.
19. Ganesan J, Ramanujam D, Sassi Y, Ahles A, Jentzsch C, Werfel S, Leierseder S, Loyer X, Giacca M, Zentilin L, Thum T, Laggerbauer B, Engelhardt S. 2013. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation 127:2097-2106.
20. Gray C, Li M, Patel R, Reynolds CM, Vickers MH. 2014. Let-7 miRNA profiles are associated with the reversal of left ventricular hypertrophy and hypertension in adult male offspring from mothers undernourished during pregnancy after preweaning growth hormone treatment. Endocrinology 155:4808-4817.
21. Grueter CE, van Rooij E, Johnson BA, DeLeon SM, Sutherland LB, Qi X, Gautron L, Elmquist JK, Bassel-Duby R, Olson EN. 2012. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149:671-683.
22. Guo R, Zhang Y, Turdi S, Ren J. 2013. Adiponectin knockout accentuates high fat diet- induced obesity and cardiac dysfunction: Role of autophagy. Biochem Biophys Acta 1832:1136-1148.
23. Han M, Yang Z, Sayed D, He M, Gao S, Lin L, Yoon S, Abdellatif M. 2012. GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy. Cardiovasc Res 93:645-654.
24. Hotamisligil GS. 2010. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900-917.
25. Hsu SD, Tseng YT, Shrestha S, Lin YL, Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, Jian TY, Lin FM, Chang TH, Weng SL, Liao KW, Liao IE, Liu CC, Huang HD. 2014. MiRTarBase update 2014: An information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 42:D78-D85.
26. Hua Y, Zhang Y, Dolence J, Shi GP, Ren J, Nair S. 2013. Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction. Diabetes 62:498-509.
27. Huang X, Charbeneau RA, Fu Y, Kaur K, Gerin I, MacDougald OA, Neubig RR. 2008. Resistance to diet-induced obesity and improved insulin sensitivity in mice with a regulator of G protein signaling-insensitive G184S Gnai2 allele. Diabetes 57:77-85.
28. Huang ZP, Chen J, Seok HY, Zhang Z, Kataoka M, Hu X, Wang DZ. 2013. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res 112:1234-1243.
29. Ikeda S, He A, Kong SW, Lu J, Bejar R, Bodyak N, Lee KH, Ma Q, Kang PM, Golub TR, Pu WT. 2009. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol 29:2193-2204.
30. Karmazyn M, Rajapurohitam V. 2014. Leptin as a cardiac pro-hypertrophic factor and its potential role in the development of heart failure. Curr Pharm Des 20:646-651.
31. Kriegel AJ, Liu Y, Fang Y, Ding X, Liang M. 2012. The miR-29 family: Genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics 44:237-244.
32. Kumarswamy R, Thum T. 2013. Non-coding RNAs in cardiac remodeling and heart failure. Circ Res 113:676-689.
33. Kuwabara Y, Horie T, Baba O, Watanabe S, Nishiga M, Usami S, Izuhara M, Nakao T, Nishino T, Otsu K, Kita T, Kimura T, Ono K. 2015. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Circ Res 116:279-288.
34. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25.
35. Leptidis S, El Azzouzi H, Lok SI, de Weger R, Olieslagers S, Kisters N, Silva GJ, Heymans S, Cuppen E, Berezikov E, De Windt LJ, da Costa Martins P. 2013. A deep sequencing approach to uncover the miRNOME in the human heart. PLoS ONE 8:e57800.
36. Li C, Li X, Gao X, Zhang R, Zhang Y, Liang H, Xu C, Du W, Zhang Y, Liu X, Ma N, Xu Z, Wang L, Chen X, Lu Y, Ju J, Yang B, Shan H. 2014a. MicroRNA-328 as a regulator of cardiac hypertrophy. Int J Cardiol 173:268-276.
37. Li Q, Xie J, Li R, Shi J, Sun J, Gu R, Ding L, Wang L, Xu B. 2014b. Overexpression of microRNA-99a attenuates heart remodelling and improves cardiac performance after myocardial infarction. J Cell Mol Med 18:919-928.
38. Liao Y, Xuan W, Zhao J, Bin J, Zhao H, Asakura M, Funahashi T, Takashima S, Kitakaze M. 2010. Antihypertrophic effects of adiponectin on cardiomyocytes are associated with the inhibition of heparin-binding epidermal growth factor signaling. Biochem Biophys Res Commun 393:519-525.
39. Littlejohns B, Pasdois P, Duggan S, Bond AR, Heesom K, Jackson CL, Angelini GD, Halestrap AP, Suleiman MS. 2014. Hearts from mice fed a non-obesogenic high-fat diet exhibit changes in their oxidative state, calcium and mitochondria in parallel with increased susceptibility to reperfusion injury. PLoS ONE 9:e100579.
40. Lu H, Buchan RJ, Cook SA. 2010. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res 86:410-420.
41. Marco A, Griffiths-Jones S. 2012. Detection of microRNAs in color space. Bioinformatics 28:318-323.
42. Marcotorchino J, Tourniaire F, Astier J, Karkeni E, Canault M, Amiot MJ, Bendahan D, Bernard M, Martin JC, Giannesini B, Landrier JF. 2014. Vitamin D protects against diet-induced obesity by enhancing fatty acid oxidation. J Nutr Biochem 25:1077-1083.
43. Martinelli NC, Cohen CR, Santos KG, Castro MA, Biolo A, Frick L, Silvello D, Lopes A, Schneider S, Andrades ME, Clausell N, Matte U, Rohde LE. 2014. An analysis of the global expression of microRNAs in an experimental model of physiological left ventricular hypertrophy. PLoS ONE 9:e93271.
44. Martínez-Martínez E, Jurado-López R, Valero-Muñoz M, Bartolomé MV, Ballesteros S, Luaces M, Briones AM, López-Andrés N, Miana M, Cachofeiro V. 2014. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: Potential role in obesity. J Hypertens 32:1104-1114.
45. Matkovich SJ, Hu Y, Eschenbacher WH, Dorn LE, Dorn GW 2nd. 2012. Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. Circ Res 111:521-531.
46. Nagalingam RS, Sundaresan NR, Gupta MP, Geenen DL, Solaro RJ, Gupta M. 2013. A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling. J Biol Chem 288:11216-11232.
47. Neppl RL, Wang DZ. 2014. The myriad essential roles of microRNAs in cardiovascular homeostasis and disease. Genes Dis 1:18-39.
48. Noyan-Ashraf MH, Shikatani EA, Schuiki I, Mukovozov I, Wu J, Li RK, Volchuk A, Robinson LA, Billia F, Drucker DJ, Husain M. 2013. A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity. Circulation 127:74-85.
49. Poudyal H, Panchal SK, Ward LC, Waanders J, Brown L. 2012. Chronic high- carbohydrate, high-fat feeding in rats induces reversible metabolic, cardiovascular, and liver changes. Am J Physiol Endocrinol Metab 302:E1472-E1482.
50. Qin F, Siwik DA, Luptak I, Hou X, Wang L, Higuchi A, Weisbrod RM, Ouchi N, Tu VH, Calamaras TD, Miller EJ, Verbeuren TJ, Walsh K, Cohen RA, Colucci WS. 2012. The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice. Circulation 125:1757-1764.
51. Rebuffé-Scrive M, Surwit R, Feinglos M, Kuhn C, Rodin J. 1993. Regional fat Distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. Metabolism 42:1405-1409.
52. Robinson MD, McCarthy DJ, Smyth GK. 2010. EdgeR: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139-140.
53. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. 2007. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100:416-424.
54. Sharma N, Okere IC, Duda MK, Chess DJ, O'Shea KM, Stanley WC. 2007. Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy. Cardiovasc Res 73:257-268.
55. Sharma S, Liu J, Wei J, Yuan H, Zhang T, Bishopric NH. 2012. Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy. EMBO Mol Med 4:617-632.
56. Song XW, Li Q, Lin L, Wang XC, Li DF, Wang GK, Ren AJ, Wang YR, Qin YW, Yuan WJ, Jing Q. 2010. MicroRNAs are dynamically regulated in hypertrophic hearts and miR-199a is essential for the maintenance of cell size in cardiomyocytes. J Cell Physiol 225:437-443.
57. Sweeney G. 2010. Cardiovascular effects of leptin. Nat Rev Cardiol 7:22-29.
58. Takano AP, Diniz GP, Barreto-Chaves ML. 2013. AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth. Mol Cell Endocrinol 376:43-50.
59. Teekakirikul P, Eminaga S, Toka O, Alcalai R, Wang L, Wakimoto H, Nayor M, Konno T, Gorham JM, Wolf CM, Kim JB, Schmitt JP, Molkentin JD, Norris RA, Tager AM, Hoffman SR, Markwald RR, Seidman CE, Seidman JG. 2010. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. J Clin Invest 120:3520-3529.
60. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S. 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980-984.
61. Tijsen AJ, van der Made I, van den Hoogenhof MM, Wijnen WJ, van Deel ED, de Groot NE, Alekseev S, Fluiter K, Schroen B, Goumans MJ, van der Velden J, Duncker DJ, Pinto YM, Creemers EE. 2014. The microRNA-15 family inhibits the TGFβ- pathway in the heart. Cardiovasc Res 104:61-71.
62. Tikellis C, Thomas MC, Harcourt BE, Coughlan MT, Pete J, Bialkowski K, Tan A, Bierhaus A, Cooper ME, Forbes JM. 2008. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am J Physiol Endocrinol Metab 295:E323-E330.
63. Turdi S, Kandadi MR, Zhao J, Huff AF, Du M, Ren J. 2011. Deficiency in AMP- activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J Mol Cell Cardiol 50:712-722.
64. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. 2006. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103:18255-18260.
65. van Rooij E, Marshall WS, Olson EN. 2008a. Toward microRNA-based therapeutics for heart disease: The sense in antisense. Circ Res 103:919-928.
66. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. 2008b. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105:13027-13032.
67. von Bibra H, St John SM. 2010. Diastolic dysfunction in diabetes and the metabolic syndrome: Promising potential for diagnosis and prognosis. Diabetologia 53:1033-1045.
68. Wang J, Duncan D, Shi Z, Zhang B. 2013. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): Update 2013. Nucleic Acids Res 41:W77-W83.
69. West DB, Boozer CN, Moody DL, Atkinson RL. 1992. Dietary obesity in nine inbred mouse strains. Am J Physiol 262:R1025-R1032.
70. Whaley-Connell A, Sowers JR. 2011. Indices of obesity and cardiometabolic risk. Hypertension 58:991-993.
71. Wisse BE, Kim F, Schwartz MW. 2007. Physiology. An integrative view of obesity. Science 318:928-929.
72. Yildirim SS, Akman D, Catalucci D, Turan B. 2013. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: Junctin as a target protein of miR-1. Cell Biochem Biophys 67:1397-1408.
73. Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu WT, Jegga AG, Fan GC. 2010. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol 49:841-850.
74. Zhang Y, Yuan M, Bradley KM, Dong F, Anversa P, Ren J. 2012. Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: Role of insulin signaling and mitochondrial function. Hypertension 59:680-693.
75. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. 2000. Lipotoxic heart disease in obese rats: Implications for human obesity. Proc Natl Acad Sci USA 97:1784-1789.